Close Menu

NEW YORK (GenomeWeb) – Epigenomics on Thursday lowered its revenue guidance for 2017 to a range of between €1 million ($1.1 million) and €1.5 million from a previous guidance of about €2.5 million.

The firm attributed the change to lower-than-expected revenues for the first half of the year, about €500,000, and added that it anticipates a continued lack of reimbursement coverage for the rest of the year in the US. In May the firm reported a 5 percent drop in revenues for the first quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.